Seeking Alpha bullishness clashes with DeepValue's WAIT on Astera Labs' valuation and concentration risks

What happened

Astera Labs reported record Q2 2026 results with revenue of $392.4 million (up 104% y/y) and GAAP net income of $153.1 million, driven by AI data center demand. Seeking Alpha published a bullish article on August 25, 2026, arguing that despite a recent share price correction from a peak of $483 to $361.67 (as of August 4), the stock remains underpriced given hyperscaler CapEx acceleration and product mix-driven margin expansion. However, the DeepValue master report rates ALAB a WAIT with conviction 3.5, noting that the market already prices sustained demand and a clean Scorpio ramp, while filings show customer concentration with four customers at 13%-29% of Q2 revenue and one end customer exceeding 70% of 2025 revenue. The report also highlights gross margin pressure, with Q3 guidance of about 72% versus 73.3% in Q2 and 76.3% in Q1, due to higher Scorpio and hardware-module mix, and stock-based compensation of $112.9 million in 1H 2026. The forward setup depends on revenue breadth and margin stability, with the report suggesting attractive entry near $300 and trim above $430, implying current price offers insufficient margin of safety.

Implication

The bullish article ignores the fact that the market has already priced in a flawless Scorpio ramp, but the ramp is being achieved with lower gross margin due to hardware-heavy mix. Customer concentration remains extreme, with four customers representing 13-29% of Q2 revenue and one end customer over 70% of 2025 revenue, making the stock vulnerable to a single hyperscaler decision. Valuation is stretched, with P/E of 166.7 and EV/EBITDA of 275.1, which leaves little room for error if Q3 revenue or margin misses guidance. The DeepValue report's base, bear, and bull scenarios imply values of $340, $250, and $430, respectively, suggesting current price offers poor risk/reward with a favorable entry near $300. Investors should monitor Q3 results (guiding $540-560M revenue and ~72% gross margin) and customer diversification before adding exposure, and treat the Seeking Alpha article as a promotional buy-the-dip narrative rather than fundamental analysis.

Thesis delta

The Seeking Alpha article does not alter our WAIT rating. It reiterates the growth story but ignores the margin compression and customer concentration risks that our analysis highlights. We maintain that the stock needs either a lower entry near $300 or evidence of cleaner Scorpio scaling with stable margins and broader customer adoption before becoming more constructive.